相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparative effectiveness of combined antiplatelet treatments in acute minor ischaemic stroke
Shina Kim et al.
STROKE AND VASCULAR NEUROLOGY (2022)
Cytochrome P450 Enzymes and Drug Metabolism in Humans
Mingzhe Zhao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Ticagrelor versus Clopidogrel in CYP2C19 Loss-of-Function Carriers with Stroke or TIA
Yongjun Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Clopidogrel with aspirin in High-risk patients with Acute Non-disabling Cerebrovascular Events II (CHANCE-2): rationale and design of a multicentre randomised trial
Yongjun Wang et al.
STROKE AND VASCULAR NEUROLOGY (2021)
Pharmacogenomic polygenic response score predicts ischaemic events and cardiovascular mortality in clopidogrel-treated patients
Joshua P. Lewis et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2020)
CYP2B6 Polymorphisms Are Associated with Ischemic Stroke Risk in a Chinese Han Population
Guolong Tu et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2020)
Association Between ABCB1 Polymorphisms and Outcomes of Clopidogrel Treatment in Patients With Minor Stroke or Transient Ischemic Attack Secondary Analysis of a Randomized Clinical Trial
Yuesong Pan et al.
JAMA NEUROLOGY (2019)
Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
William J. Powers et al.
STROKE (2019)
Genetic Polymorphisms and Clopidogrel Efficacy for Acute Ischemic Stroke or Transient Ischemic Attack A Systematic Review and Meta-Analysis
Yuesong Pan et al.
CIRCULATION (2017)
Association Between CYP2C19 Loss-of-Function Allele Status and Efficacy of Clopidogrel for Risk Reduction Among Patients With Minor Stroke or Transient Ischemic Attack
Yilong Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Insights into CYP2B6-mediated drug-drug interactions
William D. Hedrich et al.
ACTA PHARMACEUTICA SINICA B (2016)
Clinical consequences of aspirin and clopidogrel resistance: an overview
M. D. Mijajlovic et al.
ACTA NEUROLOGICA SCANDINAVICA (2013)
Differential prognostic impact of high on-treatment platelet reactivity among patients with acute coronary syndromes versus stable coronary artery disease undergoing percutaneous coronary intervention
Duk-Woo Park et al.
AMERICAN HEART JOURNAL (2013)
Genetic determinants of clopidogrel responsiveness in Koreans treated with drug-eluting stents
Jin Joo Park et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack
Yongjun Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
CYP2C19*2 and other genetic variants affecting platelet response to clopidogrel in patients undergoing percutaneous coronary intervention
George Kassimis et al.
THROMBOSIS RESEARCH (2012)
Association between cytochrome P450 promoter polymorphisms and ischemic stroke
Su Kang Kim et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2012)
Identification of the Human Cytochrome P450 Enzymes Involved in the Two Oxidative Steps in the Bioactivation of Clopidogrel to Its Pharmacologically Active Metabolite
Miho Kazui et al.
DRUG METABOLISM AND DISPOSITION (2010)
Cytochrome P-450 Polymorphisms and Response to Clopidogrel.
Jessica L. Mega et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
分享论文
